InsidersTradesSigma
Track the Xintela AB stock price and the full management transaction log of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Xintela AB has logged 4 public disclosures. Market capitalisation: €162.3m. The latest transaction was filed on 9 December 2025 (Purchase). Among the most active insiders: Thomas Eldered. The full history is free.
4
Insider Decl.
n/a
Thresholds
€25,695
3 ops.
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 December 2025
Declarations4 total
300,000 shares@ €0.02380.0033% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0026875932FI:A003U534-1
279,245,785 shares0Teckningsrätt/UniträttISIN SE0026875924FI:A003U530-1
577,000 shares@ €0.02370.0063% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0026875932FI:A003U518-1
206,820 shares@ €0.02370.0023% mcap100.0% of flowBTA (betald tecknad aktie)ISIN SE0026875932FI:A003U477-1
4 of 4 declarations
About Xintela AB
Xintela AB is a biopharmaceutical company focused on developing treatments for serious diseases using its cell marking technology. It is listed on the XSTO market.